BEYOND CDMO
LIVE

Serial Number

79407434

Owner

NorthX Biologics AB

Attorney

Alexander Lazouski

Filing Date

Jun 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BEYOND CDMO Trademark

Serial Number: 79407434 • Registration: 8131585

BEYOND CDMO is a trademark filed by NorthX Biologics AB on June 28, 2024. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NorthX Biologics AB (3 trademarks)

Storjordenvägen 2

Entity Type: 99

Trademark Details

Filing Date

June 28, 2024

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research services, and technology advisory services related to pharmaceutical research and development, development of gene therapy products, and genetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks

Scientific apparatus and instruments being medical laboratory research instruments for controlling, measuring, accelerating, and transporting chemicals for use in biochemical and genetic research; Scientific apparatus and instruments, namely, apparatus and instruments being medical laboratory research instruments for use in gene therapy, plasmid DNA production, cell banking and DNA sequencing

Chemicals used in industry and science, especially proteins, enzymes and modifications thereof.

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 9, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 23, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 23, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2025 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 26, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 26, 2025 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 26, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 26, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 26, 2025 REAP
REFUSAL PROCESSED BY IB
Sep 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 26, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 25, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Feb 24, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 26, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 2, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 2, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 2, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Oct 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2024 REPR